Nutriband Inc. (NASDAQ:NTRB – Get Free Report)’s stock price traded up 1.5% during mid-day trading on Thursday . The company traded as high as $4.00 and last traded at $3.95. 13,145 shares were traded during mid-day trading, a decline of 61% from the average session volume of 34,068 shares. The stock had previously closed at $3.89.
Nutriband Trading Up 1.5 %
The firm has a 50-day moving average of $4.94 and a 200 day moving average of $5.55. The company has a market cap of $43.87 million, a P/E ratio of -5.56 and a beta of 0.99. The company has a current ratio of 4.96, a quick ratio of 4.83 and a debt-to-equity ratio of 0.01.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
See Also
- Five stocks we like better than Nutriband
- How to Plot Fibonacci Price Inflection Levels
- Top 3 Investment Themes to Watch for in 2025
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- 3 Tickers Leading a Meme Stock Revival
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
